Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
13-Valent Pneumococcal Polysaccharide Conjugate Vaccine（CRM197,TT）
BIOLOGICAL
2 trials
Sponsors
CanSino Biologics Inc.
Conditions
Bacterial Infections
Pneumococcal Infections
Streptococcal Infections
Phase 1
Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above
Completed
NCT04100772
CanSino Biologics Inc.
Bacterial Infections, Pneumococcal Infections, Streptococcal Infections
Start: 2020-05-18
End: 2022-08-23
Updated: 2022-10-31
Phase 3
Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)
Completed
NCT04841369
CanSino Biologics Inc.
Bacterial Infections, Pneumococcal Infections, Streptococcal Infections
Start: 2021-04-13
End: 2022-09-20
Updated: 2024-04-02
Related Papers
The Safety and Immunogenicity of a 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/TT) in 12-23-Month Children: A Double-Blind, Randomized, Phase III Trial in China.
2025-11-24